Chemotherapy With Bevacizumab Does Not Affect Liver Regeneration After Portal Vein Embolization in the Treatment of Colorectal Liver Metastases
Background Blockage of vascular endothelial growth factor (VEGF) in murine models has been shown to impair liver regeneration after partial hepatectomy. The aim of this study was to evaluate the effects of chemotherapy with or without bevacizumab (monoclonal antibody anti-VEGF) on liver regeneration...
Saved in:
| Main Author: | Zorzi, Daria (author) |
|---|---|
| Other Authors: | Chun, Yun Shin (author), Madoff, David C. (author), Abdalla, Eddie K. (author), Vauthey, Jean-Nicolas (author) |
| Format: | article |
| Published: |
2008
|
| Online Access: | http://hdl.handle.net/10725/2596 http://dx.doi.org/10.1245/s10434-008-0035-7 http://link.springer.com/article/10.1245/s10434-008-0035-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Portal thrombosis and steatosis after preoperativechemotherapy with FOLFIRI-bevacizumab for colorectal liver metastases
by: Abdalla, Eddie
Published: (2006) -
Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases
by: Zorzi, D.
Published: (2007) -
Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases
by: Zorzi, Daria
Published: (2006) -
Extended Preoperative Chemotherapy Does Not Improve Pathologic Response and Increases Postoperative Liver Insufficiency After Hepatic Resection for Colorectal Liver Metastases
by: Kishi, Yoji
Published: (2010) -
Portal vein embolization
by: Abdalla, Eddie
Published: (2001)